Atrys Health reached an agreement to acquire the entire capital of Bienzobas Salud for 76.3 million euros, as reported on Monday to the National Securities Market Commission (CNMV).
On June 7, Spanish Atrys signed a purchase agreement to acquire 100 % of the share capital of Significant Impact Systems, which, in turn, owns 100 % of the share capital of Bienzobas Salud.
Of the agreed amount, 72.1 million will be paid in cash and the remaining 4.27 will be delivered in Atrys shares. Additionally, the payment of a contingent price of approximately 18.1 million has been agreed, subject to the level of gross operating profit (Ebitda) reached by Bienzobas in 2022.
Bienzobas is a company specializing in the provision and management of medical oncology services with a growing presence in Mexico and Portugal, being responsible for the oncology treatment of a reference population of two million policyholders.
State-of-the-art technology in healthcare management
The company acquired by Atrys has developed its own technological platform, based on the use of ‘cloud’ systems and services and interoperable with clinical record systems, aimed at optimizing healthcare management.
The new technologies it uses, such as ‘Big Data’ and Artificial Intelligence, allow process efficiency and advanced data analytics, managing knowledge and supporting healthcare professionals in decision-making.
At an accounting level, Atrys estimates that the operation will increase the proforma adjusted Ebitda per share for the year 2021 from 0.58 to 0.61 euros per share, 4.6 % more. The figure would rise to 0.65 euros per share post achievement of synergies in 2023, which represents an improvement of 11.4 %.
Click the link to subscribe to our news and media group on Telegram: https://t.me/G_ELSUMARIO_Noticias
Source: dpa
